Urea cycle disorders—update

S Matsumoto, J Häberle, J Kido, H Mitsubuchi… - Journal of human …, 2019 - nature.com
The urea cycle is a metabolic pathway for the disposal of excess nitrogen, which arises
primarily as ammonia. Nitrogen is essential for growth and life-maintenance, but excessive …

Gene therapy for urea cycle defects: An update from historical perspectives to future prospects

C Duff, IE Alexander, J Baruteau - Journal of Inherited …, 2024 - Wiley Online Library
Urea cycle defects (UCDs) are severe inherited metabolic diseases with high unmet needs
which present a permanent risk of hyperammonaemic decompensation and subsequent …

mRNA therapy corrects defective glutathione metabolism and restores ureagenesis in preclinical argininosuccinic aciduria

S Gurung, OV Timmermand, D Perocheau… - Science translational …, 2024 - science.org
The urea cycle enzyme argininosuccinate lyase (ASL) enables the clearance of neurotoxic
ammonia and the biosynthesis of arginine. Patients with ASL deficiency present with …

Modelling urea cycle disorders using iPSCs

C Duff, J Baruteau - npj Regenerative Medicine, 2022 - nature.com
The urea cycle is a liver-based pathway enabling disposal of nitrogen waste. Urea cycle
disorders (UCDs) are inherited metabolic diseases caused by deficiency of enzymes or …

Neonatal gene therapy achieves sustained disease rescue of maple syrup urine disease in mice

C Pontoizeau, M Simon-Sola, C Gaborit… - Nature …, 2022 - nature.com
Maple syrup urine disease (MSUD) is a rare recessively inherited metabolic disorder
causing accumulation of branched chain amino acids leading to neonatal death, if …

Successful treatment of severe MSUD in Bckdhb−/− mice with neonatal AAV gene therapy

C Pontoizeau, C Gaborit, N Tual… - Journal of Inherited …, 2024 - Wiley Online Library
Maple syrup urine disease (MSUD) is rare autosomal recessive metabolic disorder caused
by the dysfunction of the mitochondrial branched‐chain 2‐ketoacid dehydrogenase (BCKD) …

The challenge of understanding and predicting phenotypic diversity in urea cycle disorders

R Posset, M Zielonka, F Gleich… - Journal of Inherited …, 2023 - Wiley Online Library
Abstract The Urea Cycle Disorders Consortium (UCDC) and the European registry and
network for Intoxication type Metabolic Diseases (E‐IMD) are the worldwide largest …

ASL expression in ALDH1A1+ neurons in the substantia nigra metabolically contributes to neurodegenerative phenotype

S Lerner, R Eilam, L Adler, J Baruteau, T Kreiser… - Human genetics, 2021 - Springer
Argininosuccinate lyase (ASL) is essential for the NO-dependent regulation of tyrosine
hydroxylase (TH) and thus for catecholamine production. Using a conditional mouse model …

Argininosuccinic aciduria: recent pathophysiological insights and therapeutic prospects

J Baruteau, C Diez‐Fernandez, S Lerner… - Journal of inherited …, 2019 - Wiley Online Library
The first patients affected by argininosuccinic aciduria (ASA) were reported 60 years ago.
The clinical presentation was initially described as similar to other urea cycle defects, but …

ASL mRNA-LNP Therapeutic for the Treatment of Argininosuccinic Aciduria Enables Survival Benefit in a Mouse Model

O Daly, AJ Mahiny, S Majeski, K McClintock, J Reichert… - Biomedicines, 2023 - mdpi.com
Argininosuccinic aciduria (ASA) is a metabolic disorder caused by a deficiency in
argininosuccinate lyase (ASL), which cleaves argininosuccinic acid to arginine and fumarate …